Dear Editor,
Klebsiella pneumoniae (Kp) has become the most important bacterial pathogen causing high mortality rates in clinical patients due to the continuous evolution to several important variants such as carbapenem-resistant (CR-Kp), hypervirulent (hvKp) and both CR and hv K. pneumoniae (CR-hvKp). The high mortality caused by clinical hvKp is attributed to the non-response to antibiotic treatment. Therefore, a comprehensive understanding of hvKp-host interaction, especially the hvKp-mediated immune responses, is necessary. Although Kp-host interaction has been studied for more than 20 years, most research showed that pro-inflammatory signaling was crucial to Kp clearance in the host,1 without providing evidence to explain why hvKp causes a high rate of death.
To investigate the underlying mechanisms of hvKp pathogenesis, we first infected mice with 17ZR101, a K2 hvKp clinical strain, and HKU1, a classical Kp (cKp) strain, and evaluated the distinct immunological responses elicited in the animals. Antimicrobial susceptibility tests performed on these two strains showed that they were resistant to cefotaxime and meropenem but remained susceptible to amikacin, polymyxin B, and tigecycline (Supplementary Table 1). We found that mice infected by 17ZR101, but not HKU1 or the hvKp control strains HvKP4 and HvKP1088, died within 24 h post-infection (hpi)2,3,4 (Fig. 1a) with a series of tissue damages in various organs (Fig. 1b; Supplementary Fig. 1a, b). 17ZR101-infection resulted in significantly higher bacterial burdens in various organs at 12 hpi when compared with HKU1-infected animals (Fig. 1c). Intracellular bacteria counting showed that although 17ZR101 could be readily engulfed, this strain could survive within phagocytes (Fig. 1d). Moreover, we found that the animals infected by a K2-hvKp virulence plasmid-cured strain (17ZR101-PC) all survived (Fig. 1a; Supplementary Fig. 1c) with similar tissue damage to those infected by HKU1 (Fig. 1a, b; Supplementary Fig. 1a, b), which was reversed by virulence plasmid complementary strain 17ZR101-PC-TC (Fig. 1a), confirming that the virulence plasmid played a critical role in the pathogenesis of hvKp by enabling better survival within the host.
Since strain 17ZR101 could be engulfed by phagocytes but was still able to cause severe infections, we hypothesized that the symptoms of infections were caused by the strong and over-active immune responses elicited by hvKp. To characterize the immune landscape in hvKp-infected lungs, we performed the single-cell RNA-Seq (scRNA-seq) to investigate the immune heterogeneity of the infected lung. Using scRNA-seq and an integrated quality control pipeline, we generated a lung atlas that profiled 21,298 cells, including 10,489 from 17ZR101-infected lungs and 10,809 from sham-treated lungs. We visualized the data with dimensionality reduction using uniform manifold approximation and projection (UMAP) and identified 10 major cell types (Fig. 1e; Supplementary Fig. 2a). Notably, 17ZR101-infection reduced the frequency of all lymphocyte compartments and alveolar macrophages (AMs) and increased the levels of interstitial macrophages (IMs) and neutrophils (Neus) (Supplementary Fig. 2b, c), indicating that IMs and Neus are the major sources of dysregulated inflammation in 17ZR101 infection. Also, IMs and Neus activation was associated with significant changes in several pathways, related to leukocyte migration, cytokine production, and inflammatory responses (Supplementary Fig. 3a). Reclustering of IMs and Neus revealed an increased M1-like subpopulation (Aif1+Ctsb+) (Supplementary Fig. 3b) and a pro-inflammatory neutrophil subset (Ngp+Cd177+) (Supplementary Fig. 3c) in 17ZR101-infected lungs. Altogether, these results uncovered that the dysregulation of cytokine production and inflammatory response are the main features of IMs and Neus following 17ZR101 infection.
To validate these scRNA-seq observations, we analyzed the changes in the amount and types of immune cells and signaling molecules of the immune system in the lungs of mice infected by 17ZR101 and observed markedly increased infiltration of IMs (Ly6C+CD11b+CD11c− SiglecF−) and Neus (CD11b+Ly6G+) in these organs (Fig. 1f, g). Consistent with their microbicidal activity role, studies have identified Kp infection triggers the recruitment of IMs.1,5,6 The infiltrated IMs were also found to express higher levels of CD80 proteins at their surface, indicating that the proinflammatory M1 polarization process has been enhanced (Fig. 1g). High-throughput RNA sequencing (RNA-seq) analysis of total RNA isolated from the lungs of 17ZR101-infected mice further revealed cytokine production, cell chemotaxis, and extracellular matrix organization were depicted during infection by 17ZR101 (Supplementary Fig. 4), confirming that hvKp infection triggered strong inflammatory responses in the host. In addition, 17ZR101-infected mice exhibited over a 100-fold increase in the levels of serum interleukin (IL)-6, interferon (IFN)-γ, and IL-1β (Fig. 1h). Taken together, these findings confirmed the flow cytometry data that 17ZR101 induced M1 polarization and neutrophil chemotaxis, which is characteristic of a cytokine storm.
Among these known macrophage polarization regulation factors, Stat1 expression (Log2 fold change: 2.700) was found to increase dramatically upon 17ZR101 infection (Supplementary Fig. 5a, b), indicating that this pathway became active during infection. Particularly, our qPCR result confirmed a 5.2-fold increase in the expression of Stat1 (Supplementary Fig. 5c). More convincingly, Stat1 was highly expressed in 17ZR101-infected IMs and Neus revealed by scRNA-Seq (Fig. 1i), and up-regulated STAT1 and phosphorylated STAT1 (p-STAT1) by western blotting (Fig. 1j). Flow cytometric analysis confirmed that STAT1 was phosphorylated in infected IMs and Neus (Supplementary Fig. 5d) and NK cells were a major source of IFN-γ upon 17ZR101 infection (Supplementary Fig. 5e). These findings indicated both up-regulated STAT1 biosynthesis and phosphorylation were associated with hvKp-induced IMs M1 polarization and Neus activation. Importantly, mice infected with 17ZR101 and intraperitoneally administrated with STAT1 inhibitor, Fludarabine (F-ara), protected 50% of mice from death within 48 h (Fig. 1k), and significantly reduce the serum IFN-γ level at 12 hpi (Fig. 1l). Together, these results confirmed that hvKp-induced cytokine storm was at least partially STAT1-dependent, which is consistent with its role as the pivotal mediator of M1 macrophage polarization.7
Since hvKp infection led to mortality by inducing cytokine storm, we then tested the therapeutic value of non-steroidal anti-inflammatory drugs (NSAIDs) on hvKp-infected mice. Administration of acetylsalicylic acid (ASA), an inhibitor of cyclooxygenase-1 enzyme, which controls the production of thromboxane A2 and proinflammatory prostaglandins,8 protected 100% of the mice infected by 17ZR101 within 48 h (Fig. 1m), suggesting that reversing cytokine storm could protect mortality caused by hvKp infection, which further confirming the key role of cytokine storm on mortality caused by hvKp infection. Consistently, ASA treatment was shown to suppress IMs and Neus infiltration into the lungs, inhibit M1 macrophage polarization during hvKp infection and drastically reduce serum cytokine production. Furthermore, ASA treatment was shown to inhibit Stat1 expressions (−1.056) and down-regulate expression of three STAT1-regulated chemokines, namely Cxcl9 (−2.118), Cxcl10 (−3.590) and Cxcl11(−2.098) (Supplementary Fig. 6), confirming that STAT1 is a key transcriptional factor involved in hvKp-induced IMs polarization, Neus recruitment and production of the cytokine storm.
ASA could protect against sepsis shock due to cytokine storm, but it is unable to eradicate hvKp in the host. We then explore a combination therapy of ASA and antibiotics, which could not only save patients from sepsis shock caused by severe hvKp infection, but also eradicate bacteria in the host by antibiotics. The treatment with a combination of ceftazidime (CAZ, 8 mg kg−1)—avibactam (AVI, 4 mg kg−1) could protect mice infected by 104 CFU of 17ZR101(Supplementary Fig. 7a, b), while not for mice infected by ~107 CFU with all mice died within 14 h (Fig. 1m). However, the combination of ASA (100 mg kg−1) with the same dose of antibiotic combination robustly rescued mice from death within 24 h, suggesting the synergistic anti-inflammatory drugs and antibiotics is both required for this process (Fig. 1n). Further analysis showed that ASA could suppress IMs infiltration (Supplementary Fig. 7c), but without contributing to bacteria clearance (Fig. 1o), indicating an anti-inflammatory role of ASA. Antibiotic (CAZ-AVI) alone could reduce the bacteria burden, but not enough to prevent mortality; even the bacterial burden was slightly higher for ASA and CAZ-AVI combinational treatment when compared to CAZ-AVI, mice were still alive suggesting the importance of the role of ASA on reversing cytokine storm (Fig. 1m, Supplementary Fig. 7d). Together, these results confirmed that the combination of ASA and antibiotics was more efficient in treating severe hvKp infection.
Data availability
All data and materials presented in this study are available on request.
References
Xiong, H. et al. Innate lymphocyte/Ly6Chi monocyte crosstalk promotes Klebsiella pneumoniae clearance. Cell 165, 679–689 (2016).
Xie, M. et al. Clinical evolution of ST11 carbapenem resistant and hypervirulent Klebsiella pneumoniae. Commun. Biol. 4, 1–9 (2021).
Xie, M. et al. Conjugation of virulence plasmid in clinical Klebsiella pneumoniae strains through formation of a fusion plasmid. Adv. Biosyst. 4, 1900239 (2020).
Yang, X., Wai-Chi Chan, E., Zhang, R. & Chen, S. A conjugative plasmid that augments virulence in Klebsiella pneumoniae. Nat. Microbiol. 4, 2039–2043 (2019).
Dumigan, A. et al. In vivo single‐cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection. EMBO Mol. Med. 14, e16888 (2022).
Xiong, H. et al. Distinct contributions of neutrophils and CCR2+ monocytes to pulmonary clearance of different Klebsiella pneumoniae strains. Infect. Immun. 83, 3418–3427 (2015).
Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750–761 (2011).
Abani, O. et al. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 399, 143–151 (2022).
Acknowledgements
This study was funded by the Theme-Based Research Scheme (T11-104/22-R) and the Research Impact Fund (R5011-18F) from the Research Grant Council of the Government of Hong Kong SAR.
Author information
Authors and Affiliations
Contributions
Q.X. performed the experiments and drafted the manuscript; Q.X., G.Y., and S.C. designed the project; M.X. and X.L. helped with the animal experiments; H.H. analyzed the scRNA- and RNA-Sequencing data; X.L., H.W., and C.Y. helped with flow cytometry analysis; G.Y. and S.C. supervised the project and wrote the manuscript. E.W.C.C. and R.Z. edited the manuscript. All authors read and approved the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xu, Q., Xie, M., Liu, X. et al. Molecular mechanisms underlying the high mortality of hypervirulent Klebsiella pneumoniae and its effective therapy development. Sig Transduct Target Ther 8, 221 (2023). https://doi.org/10.1038/s41392-023-01490-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41392-023-01490-9